Indoco Remedies stock soars over 5% on USFDA approval for opioids drug ...Middle East

Business Standard - Economy
Indoco Remedies stock soars over 5% on USFDA approval for opioids drug
Indoco Remedies stock surged up to 5.53 per cent at Rs 358.60 per share on the BSE in Wednesday's intraday deals

Hence then, the article about indoco remedies stock soars over 5 on usfda approval for opioids drug was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Indoco Remedies stock soars over 5% on USFDA approval for opioids drug )

Apple Storegoogle play

Last updated :

Also on site :



Latest News